- Previous Close
0.00 - Open
42.00 - Bid 12.17 x 40000
- Ask 17.48 x 45100
- Day's Range
7.94 - 7.94 - 52 Week Range
7.94 - 42.00 - Volume
3,744 - Avg. Volume
0 - Market Cap (intraday)
4.926B - Beta (5Y Monthly) 1.59
- PE Ratio (TTM)
61.76 - EPS (TTM)
0.68 - Earnings Date Apr 25, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date May 9, 2025
- 1y Target Est
--
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for surgery, thoracic medicine, neurology, wound care, anaesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare, as well as assistive technology for senior citizens and disabled children. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, rest of Europe, and internationally. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
www.add.life2,311
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ADDLF
View MorePerformance Overview: ADDLF
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ADDLF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ADDLF
View MoreValuation Measures
Market Cap
1.83B
Enterprise Value
2.31B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
2.45%
Return on Assets (ttm)
3.52%
Return on Equity (ttm)
4.95%
Revenue (ttm)
10.29B
Net Income Avi to Common (ttm)
252M
Diluted EPS (ttm)
0.68
Balance Sheet and Cash Flow
Total Cash (mrq)
331M
Total Debt/Equity (mrq)
95.52%
Levered Free Cash Flow (ttm)
839.88M